SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.

By T. Abrams, Leslie B. Lee, Lesley J. Murray, N. Pryer, J. Cherrington. Molecular Cancer Therapeutics, 2003

666 citations recorded by the source corpus.